Analystreport

AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..

AtriCure, Inc.  (ATRC) 
Last atricure, inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atricure.com